Holdings Information

Bibliographic Record Display

• Title:Clinical handbook of psychotropic drugs for children and adolescents / [edited by] Dean Elbe, BSc (Pharm), BCPP, Department of Child and Adolescent Mental Health, Children's & Women's Health Centre of British Columbia, Vancouver, BC, Columbia, Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Kalyna Z. Bezchlibnyk-Butler, BScPhm, FCSHP, Adil S. Virani, BSc (Pharm), PharmD, FCSHP, Lower Mainland Pharmacy Services and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Ric M. Procyshyn, BSc (Pharm), MSc, PharmD, PhD, British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
  
•    
• Other Contributors/Collections:Elbe, Dean, editor.
  Bezchlibnyk-Butler, Kalyna Z., 1947- editor.
  Virani, Adil S., editor.
  Procyshyn, Ric M. (Ric Michael), 1961- editor.
  
• Published/Created:Boston, MA : Hogrefe, [2015]
  

• Holdings

  Holdings Record Display

  • Location:WOODWARD LIBRARY stacksWhere is this?
    
  • Call Number: QV77.2 .C546 2015
    
  • Number of Items:1
    
  • Status:Available
    

   
• Library of Congress Subjects:Psychotropic drugs.
  Pediatric psychopharmacology.
  Adolescent psychopharmacology.
  Mental illness--Chemotherapy.
  
• Medical Subjects: Psychotropic Drugs--therapeutic use--Handbooks.
  Adolescent.
  Child.
  
• Genre/Form:Handbooks and manuals.
  
• Edition:3rd edition.
  
• Description:362 pages : illustrations (some color) ; 28 cm
  
• Additional formats:Issued also in electronic format.
  
• Notes:Text runs parallel to spine.
  Revision of: Clinical handbook of psychotropic drugs for children and adolescents / Kalyna Z. Bezchlibnyk-Butler, Adil S. Virani, [eds.]. -- 2nd rev. ed. -- Toronto : Hogrefe & Huber, c2007.
  Includes bibliographical references and index.
  
• ISBN:9780889374560 (pbk.)
  0889374562 (pbk.)
  9781616764562 (pdf)
  
• Contents:Machine generated contents note: Psychiatric Disorders in Children and Adolescents
  Attention-Deficit/Hyperactivity Disorder (ADHD)
  Major Depressive Disorder (MDD)
  Disruptive Mood Dysregulation Disorder (DMDD)
  Bipolar Disorder (BD)
  Schizophrenia
  Anxiety Disorders
  Separation Anxiety Disorder
  Generalized Anxiety Disorder (GAD)
  Social Anxiety Disorder
  Panic Disorder
  Specific Phobia
  Obsessive-Compulsive Disorder (OCD)
  Trauma- And Stressor-Related Disorders
  Posttraumatic Stress Disorder (PTSD)
  TIC Disorders
  Tourette's Disorder
  Autism Spectrum Disorder (ASD)
  Disruptive, Impulse-Control, And Conduct Disorders
  Conduct Disorder (CD)
  Oppositional Defiant Disorder (ODD)
  Drugs for ADHD
  Psychostimulants
  Atomoxetine
  Comparison of Drugs for ADHD
  α2 agonists
  Augmentation Strategies in ADHD
  Antidepressants
  Selective Serotonin Reuptake Inhibitors (SSRI)
  Norepinephrine Dopamine Reuptake Inhibitor (NDRI)
  Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
  Serotonin-2 Antagonists/Reuptake Inhibitors (SARI)
  Serotonin-1A Agonist/Serotonin Reuptake Inhibitor
  Noradrenergic/Specific Serotonergic Antidepressants (NaSSA)
  Nonselective Cyclic Antidepressants
  Monoamine Oxidase Inhibitors
  Reversible Inhibitor of MAO-A (RIMA)
  Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs)
  Effects of Antidepressants on Neurotransmitters/Receptors
  Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors
  Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses
  Antidepressant Doses and Pharmacokinetics
  Switching Antidepressants
  Antidepressant Augmentation Strategies
  Electroconvulsive Therapy (ECT)
  Antipsychotics
  "Second-Generation" Antipsychotics/SGAs
  "Third-Generation" Antipsychotic/TGA
  "First-Generation" Antipsychotics/FGAs
  Effects of Antipsychotics on Neurotransmitters/ Receptors
  Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors
  Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses
  Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections)
  Comparison of Long-Acting IM Antipsychotics
  Switching Antipsychotics
  Antipsychotic Augmentation Strategies
  Antipsychotic-Induced Extrapyramidal Side Effects (EPSE) and Their Management
  Extrapyramidal Side Effects of Antipsychotics
  Treatment Options for Extrapyramidal Side Effects
  Effects on Extrapyramidal Symptoms
  Comparison of Agents for Treating Acute Extrapyramidal Side Effects
  Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects
  Anxiolytic (Antianxiety) Agents
  Benzodiazepines
  Comparison of the Benzodiazepines
  Buspirone
  Hypnotics/Sedatives
  Comparison of Hypnotics/Sedatives
  Mood Stabilizers
  Lithium
  Anticonvulsants
  Comparison of Anticonvulsants
  Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses
  Drugs/Substances of Abuse
  Alcohol
  Stimulants
  Hallucinogens
  Opioids
  Inhalants/Aerosols
  Sodium Oxybate (Gamma-Hydroxybutyrate
  GHB)
  Flunitrazepam (Rohypnol)
  Nicotine/Tobacco
  Treatment of Substance Use Disorders
  Disulfiram
  Acamprosate
  Naltrexone
  Methadone
  Buprenorphine
  Pharmacotherapy for Nicotine/Tobacco Use Dependence
  Unapproved Treatments of Psychiatric Disorders
  Adrenergic Agents
  Cholinergic Agents
  Dopaminergic Agents
  GABA Agents/Anticonvulsants
  Miscellaneous
  NMDA Agents
  Natural Health Products.